Treatment News : 5.2 Million People With HIV in Low- and Middle-Income Countries Now on Treatment - by Tim Horn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » July 2010

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


July 20, 2010

5.2 Million People With HIV in Low- and Middle-Income Countries Now on Treatment

by Tim Horn

An estimated 5.2 million people in low and middle-income countries were receiving lifesaving HIV treatment at the end of 2009, according to a World Health Organization (WHO) update on Monday, July 19, at the XVIII International AIDS Conference (IAC) in Vienna. 

Since 2003—which marked the launch of the historic “3 by 5” initiative to provide access to HIV treatment to 3 million people living in low- and middle-income countries by the end of 2005—the number of people receiving HIV treatment has increased 12-fold.

WHO estimates that 1.2 million people started treatment in 2009, bringing the total number of people receiving treatment to 5.2 million, compared with 4 million at the end of 2008.

“This is the largest increase in people accessing treatment in a single year. It is an extremely encouraging development,” said Hiroki Nakatani, MD, PhD, the WHO assistant director-general for HIV, Tuberculosis, Malaria and Neglected Tropical Diseases.

At IAC, WHO is calling for earlier treatment for people with HIV, in the form of a 2010 revision to its treatment guidelines. The objective is to begin HIV treatment before they become ill because of weakened immunity.

WHO 2010 HIV Treatment Guidelines  

The World Health Organization's HIV treatment guidelines: "Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach," updated 2010.


WHO previously recommended starting HIV treatment when a person’s CD4 count drops below 200 cells, but it now advises starting HIV treatment at 350 cells or below.

“Starting treatment earlier gives us an opportunity to enable people living with HIV to stay healthier and live longer,” said Gottfried Hirnschall, MD, WHO director of HIV/AIDS.

Estimates developed through epidemiological modeling suggest that HIV-related mortality can be reduced by 20 percent between 2010 and 2015 if these guidelines for early treatment are broadly implemented.

Earlier treatment can prevent opportunistic infections including tuberculosis (TB), the No. 1 killer of people with HIV. Deaths from TB can be reduced by as much as 90 percent, Hirnschall suggested, if people with both HIV and TB start treatment earlier.
Along with reductions in morbidity, earlier HIV treatment in low- and middle-income countries will ultimately reduce the costs of hospital care.

Hirnschall also pointed out that earlier treatment might have prevention benefits. “Because treatment reduces the level of virus in the body,” he said, “it means HIV-positive people are less likely to pass the virus on to their partners.”

WHO’s treatment guidelines expand the number of people recommended for HIV treatment from an estimated 10 million to an estimated 15 million. The cost needed for HIV treatment in 2010 will be about $9 billion, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS).

“The investments we make today can save not only millions of lives but millions of dollars tomorrow,” said Bernhard Schwartlander, MD, director, evidence, strategy and results, UNAIDS. “People with weaker immune systems who come late for treatment require more complex and costly drugs and services than those who start treatment earlier and are healthier.”

Unfortunately, the new WHO treatment guidelines are being published just as wealthy nations are reducing support for HIV prevention and treatment programs in low- and middle-income countries. Nakatani, however, stressed that cost should not be a factor in WHO policy. “Guidelines should be evidence-based and should be applicable to anyone—rich or poor.”

Search: antiretroviral, treatment, access, international, global, developing nations, low income, middle income, World Health Organization, Vienna, International AIDS Conference

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.